Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.36 USD | +1.91% | -3.40% | -9.97% |
10/05 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
09/05 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.97% | 3.06B | |
+6.01% | 111B | |
+11.67% | 106B | |
-12.42% | 22.24B | |
+0.38% | 21.25B | |
-5.01% | 18.97B | |
-35.21% | 18.52B | |
-11.45% | 16.81B | |
+38.17% | 12.54B | |
-24.96% | 8.09B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- RBC Adjusts Xenon Pharmaceuticals' Price Target to $56 From $51, Maintains Outperform Rating